Costanzo Silvia, Godino Lea, De Summa Simona, Marvulli Tommaso Maria, Genuardi Maurizio, Di Pietro Maria Luisa, Cordisco Emanuela Lucci, Turchetti Daniela, Miccoli Sara, Deledda Giuseppe, Fantoni Giovanna, Viassolo Valeria, Brunetti Oronzo, De Luca Raffaele, Digennaro Maria, Romito Francesca, Campanella Maria, Patruno Margherita
Heredo-Familiar Cancer Clinic, IRCCS - Istituto Tumori''Giovanni Paolo II'', Bari, Italy.
Medical Genetics Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
BMC Cancer. 2025 Jul 1;25(1):1044. doi: 10.1186/s12885-025-14419-y.
Genetic testing has led to a considerable enhancement in the ability to identify individuals at risk of Hereditary Breast and Ovarian Cancer syndrome related to BRCA1/2 pathogenic variants, thus necessitating personalised prevention programs. However, barriers related to intrafamilial communication, privacy regulations, and genetic information dissemination hinder preventive care, particularly in Italy, where legal constraints limit the disclosure of genetic risks to at-risk relatives. This study examines the relationship between BRCA1/2 carriers' communication challenges and three factors: cancer status, comprehension of genetic information, and the genetic counseling pathway accessed (Traditional Genetic Counseling, TGC vs. Mainstream Cancer Genetics, MCG).
This multicenter, prospective, observational study included 277 BRCA1/2 carriers (probands and relatives) aged 18-80 from various Italian centers. Participants completed a sociodemographic form, a self-administered survey, and psychological assessments (Impact of Event Scale, IES and Distress Thermometer, DT). Categorical variables were compared using Pearson's Chi-squared test or Fisher's exact test based on sample size and expected frequencies, whereas continuous variables were analyzed using the Wilcoxon rank-sum test because of non-normal data distribution.
Among the 277 carriers (115 probands, 162 relatives), 79.4% received TGC and 20.6% MCG. The cancer prevalence was higher in probands (83%) than in relatives (22%). The probands exhibited greater psychological distress (higher IES and DT scores), and cancer-affected relatives had higher distress levels than healthy relatives (p = 0.008). While no severe psychological distress or PTSD was found, distress was more associated with cancer diagnosis than genetic status. Genetic comprehension was significantly higher in relatives (p = 0.007) and in those who underwent TGC compared to MCG (p < 0.001). TGC carriers also better understood genetic risks and management strategies (p < 0.001).
Psychological distress and genetic comprehension significantly influenced the communication. TGC enhances understanding more effectively than MCG, highlighting the need for tailored support for both carriers and healthcare professionals to improve cascade counseling and testing rates, and cancer prevention. As we look into the future, we need to critically approach MCG, and determine how to address carriers understanding and prevention needs and reincorporate a more comprehensive genetic risk assessment into the MCG model.
基因检测极大地提高了识别与BRCA1/2致病变异相关的遗传性乳腺癌和卵巢癌综合征高危个体的能力,因此需要个性化的预防方案。然而,与家族内沟通、隐私法规和基因信息传播相关的障碍阻碍了预防性护理,尤其是在意大利,法律限制限制了向高危亲属披露基因风险。本研究探讨了BRCA1/2携带者的沟通挑战与三个因素之间的关系:癌症状态、对基因信息的理解以及所采用的遗传咨询途径(传统遗传咨询,TGC与主流癌症遗传学,MCG)。
这项多中心、前瞻性、观察性研究纳入了来自意大利不同中心的277名年龄在18 - 80岁之间的BRCA1/2携带者(先证者和亲属)。参与者完成了一份社会人口学表格、一份自我管理的调查问卷以及心理评估(事件影响量表,IES和痛苦温度计,DT)。根据样本量和预期频率,使用Pearson卡方检验或Fisher精确检验比较分类变量,而由于数据分布不呈正态,使用Wilcoxon秩和检验分析连续变量。
在277名携带者(115名先证者,162名亲属)中,79.4%接受了TGC,20.6%接受了MCG。先证者的癌症患病率(83%)高于亲属(22%)。先证者表现出更大的心理困扰(IES和DT得分更高),且患癌亲属的困扰水平高于健康亲属(p = 0.008)。虽然未发现严重的心理困扰或创伤后应激障碍,但困扰与癌症诊断的关联比与基因状态的关联更大。亲属(p = 0.007)以及接受TGC的人相比于接受MCG的人,对基因的理解显著更高(p < 0.001)。接受TGC的携带者也更好地理解了基因风险和管理策略(p < 0.001)。
心理困扰和基因理解对沟通有显著影响。与MCG相比,TGC能更有效地增强理解,这突出了需要为携带者和医疗保健专业人员提供量身定制的支持,以提高级联咨询和检测率以及癌症预防。展望未来,我们需要审慎对待MCG,并确定如何满足携带者的理解和预防需求,以及如何将更全面的基因风险评估重新纳入MCG模式。